Package 33342-004-09

{"route": ["ORAL"], "spl_id": "99d52ed2-f3e5-476a-8ba6-ed2cee3aae8a", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064"], "upc": ["0333342004093"], "unii": ["99DK7FVK1H"], "rxcui": ["199422"], "spl_set_id": ["effb86cc-4b80-4fac-aaa3-9f373b3d0f7d"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (33342-004-09)", "package_ndc": "33342-004-09", "marketing_start_date": "20190128"}], "brand_name": "Nevirapine", "product_id": "33342-004_99d52ed2-f3e5-476a-8ba6-ed2cee3aae8a", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "33342-004", "generic_name": "Nevirapine", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nevirapine", "active_ingredients": [{"name": "NEVIRAPINE", "strength": "200 mg/1"}], "application_number": "ANDA090688", "marketing_category": "ANDA", "marketing_start_date": "20190128", "listing_expiration_date": "20261231"}